Stocktoria
Tenaya Therapeutics, Inc. TNYA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-30
Tenaya Therapeutics, Inc. statistics & valuation
Market cap$155.7M
P / B1.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -61.7% | -92.7% | -72.8% | -44.3% | -23.1% |
| Return on equity | -73.5% | -119.7% | -89.0% | -50.8% | -26.1% |
| Current ratio | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 |
Source: SEC EDGAR filings · CIK 0001858848 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.